Ann: ECQ Exercises Opitons to Acquire Cynata Inc , page-69

re: Ann: ECQ Exercises Opitons to Acquire Cyn... Impressive consolidation at these levels, more than I expected, which is good, I'm glad to be wrong.

Looking to be a more solid proposition now. Post consolidation, 40c might just hold, especially with the lower equity, and with the 2 new directors being experienced marketers. I believe they signed up Kathy Freeman to promote ISN.

Allogeneic stem cells is the way to go. RGS have just replaced their Autologous offering with an Allogeneic "Off-The-Shelf (OTS)" product, and also becoming involved in Cancer research using stem cells with the Kolling Institute (Watch for a paper on the release of their latest animal cancer study results in the next 2 weeks).

Will be interesting to see in 2014 what the level of investment for ECQ is from the USA, especially if they are successful in getting the BioTech grants they applied for in the USA.

I would expect if things go to plan they would be looking to list on NASDAQ at some stage.

Am continuing to pick up a few extra whenever it dips below 2c.

A good longer term hold (with the occasional small trade here and there).

Gw